Categories: The Charlton Centre

Ankylosing Spondylitis Awareness Month

Ankylosing Spondylitis Awareness Month, observed each year in May, is one of several health promotion events celebrated and endorsed by Health Canada and serves as a crucial opportunity to shed light on a chronic inflammatory disease that affects thousands of people in Canada. Ankylosing Spondylitis (AS) is a form of arthritis that primarily impacts the spine, causing pain, stiffness, and in some cases, fusion of the vertebrae. It can also affect the knees, hips, eyes, and the gastrointestinal tract, significantly impacting quality of life.

Through efforts of raising awareness, Ankylosing Spondylitis Awareness Month is aimed to increase the general understanding of the disease among the public and healthcare professionals, reducing diagnostic delays and ensuring timely access to treatment. Awareness fosters growth in the Spondyloarthritis community, advocating for new and improved advanced therapies, and improving patient quality of life.

Charlton Health Pharmacy is proud to support patients with AS through a multidisciplinary approach, working with allied health care professionals and ensuring our patients receive care of the highest quality. Some of these services include counselling on advanced therapies (ex. biologics), reimbursement navigation support, and providing access to infusion clinics across Ontario. Ultimately, Ankylosing Spondylitis Awareness Month is an opportunity to showcase the resilience of patients living with AS. Please see the Canadian Spondyloarthritis Association (CSA) for more information, resources, and support groups for people living with AS and their caregivers.

Parvinder Sahota is a clinical pharmacist and a recent graduate from the University of Toronto. He enjoys learning about the ever-evolving field of autoimmune conditions and their treatment options.

admin

Recent Posts

Winrevair: A New Treatment Option for Pulmonary Arterial Hypertension (PAH)

Pulmonary arterial hypertension occurs when there is increased pressure in the small blood vessels that…

1 week ago

New Biologic Treatment for PMR (Polymyalgia Rheumatica)

Polymyalgia rheumatica (PMR) is an inflammatory condition that causes widespread joint and muscle pain along…

3 weeks ago

Expanded Protection: RSV Vaccine Now Approved for More Adults

Respiratory Syncytial Virus (RSV) is a common virus that can cause serious lung infections, particularly in…

1 month ago

Rinvoq: A New Oral Option for Giant Cell Arteritis

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq…

2 months ago

World Arthritis and Mental Health Day: October 2025

Every year on October 12, World Arthritis Day raises awareness about the millions of people…

2 months ago

Tremfya: New Dosing Options for Crohn’s Disease and Ulcerative Colitis

Tremfya (guselkumab) has been available for several years to treat plaque psoriasis and psoriatic arthritis.…

3 months ago